オフライン状態です。これはページの読み取り専用バージョンです。
ホーム
PRIMOとは?
お知らせ&公開情報
PRIMOからのお知らせ
PRIMOの公開情報
治療開発マップ
AMEDニュース
AMED公募情報
AMED事業の成果
関連リンク
PRIMO支援
治療開発マップ
サイト内検索
研究者ログイン
Home
About PRIMO
Notices & Information
Notices from PRIMO
Information from PRIMO
AMED news
AMED calls for proposals
AMED Achievements
Related Link
Search within this website
Researcher Login
AMED news
AMED news
2019.08.22
Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis
2019.08.20
Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-wild-type Diffuse Astrocytic Gliomas
2019.08.09
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
2019.07.30
Divergent lncRNA MYMLR regulates MYC by eliciting DNA looping and promoter‐enhancer interaction
2019.07.17
Molecular Mechanism of Cellular Oxidative Stress Sensing by Keap1
2019.07.03
Fibroblast growth factor signals regulate transforming growth factor‐β‐induced endothelial‐to‐myofibroblast transition of tumor endothelial cells via Elk1
2019.06.21
Allocation of the first adjustment expenses related to R&D in the medical field for FY2019
2019.05.18
Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor
2019.05.01
De novo DNA methylation at imprinted loci during reprogramming into naive and primed pluripotency
2019.04.30
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations
2019.04.25
Joint development of a new drug targeting pancreatic cancer
2019.03.29
LC-SCRUM-Japan expands screening to Taiwan
2019.03.25
Experimental screening conducted in Hokkaido
2019.03.14
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
2019.03.06
Regnase-1-mediated post-transcriptional regulation is essential for hematopoietic stem and progenitor cell homeostasis
2019.03.06
Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in Atypical Teratoid/Rhabdoid Tumor
2019.02.20
A role for IL-34 in osteolytic disease of multiple myeloma
2019.02.13
Strong therapeutic effects confirmed in physician-led clinical trials of viral therapy for brain tumors
2019.02.04
Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma
2019.01.30
Prediction of ALK Mutations Mediating ALK-TKIs Resistance and Drug Re-purposing to Overcome the Resistance
2019.01.25
Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
2019.01.24
JCRP Cancer Symposium for Citizens held on February 23, 2019
2019.01.16
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
2019.01.11
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
2018.12.26
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells
2018.12.18
Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality
2018.12.06
Supportive care/palliative treatment research policy (overview) released
2018.11.22
Allocation of second adjustment expenses related to R&D in the medical field for FY2018
2018.11.19
Serum level of soluble CD163 may be a predictive marker of the effectiveness of nivolumab in patients with advanced cutaneous melanoma